Diurnal rhythm of crosslaps in human serum

Clinical Chemistry

Volumn 45, Issue 10, 1999, Pages 1858-1860

  Wichers, Maria ^a   Schmidt, Elke ^a   Bidlingmaier, Frank ^a   Klingmüller, Dietrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN; PYRIDINOLINE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CIRCADIAN RHYTHM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; NORMAL HUMAN; OSTEOLYSIS; URINE LEVEL;

EID: 0032830554     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.10.1858     Document Type: Article

References (13)

1. 1. Aoshima H, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Inoue T. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone 1998:22: 73-8.
2. 2. Gundberg CM, Markowitz ME, Mizruchi M, Rosen JF. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985:60:736-9.
3. 3. Greenspan SL, Dresner-Pollak R, Parker RA, Londo D, Ferguson L. Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 1997:60:419-23.
4. 4. Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int 1998:63:102-6.
5. 5. Hasaanger C, Risteli J, Risteli L, Jensen SB. Christiansen C. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992:7:1307-11.
6. 6. Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C. Measurements of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C telopeptide of type I. J Bone Miner Res 1998:12:1-7.
7. 7. Nakayama H. Yano T, Sagara Y, Ando K, Kasai V, Taketani Y. Clinical usefulness of urinary CrossLaps as a sensitive marker of bone metabolism. Endocr J 1997:44:497-84.
8. 8. Fledelius C, Kolding I, Qvist P, Bonde M, Hassanger C. Reginster JY, et al. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide α1-chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ™ ELISA. Scand J Clin Lab Investig 1997:57:73-83.
9. 9. Halberg F. Chronobiotogy. Annu Rev Physiol 1969;31:675-725.
10. 10. Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, et al. Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptide, Clin Chem 1998;44:2290-3000.
11. 11. Ju HSJ, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997:43:1570-6.
12. 12. Schlemmer A, Hassanger C, Jensen SB, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992:74:476-80.
13. 13. Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NSJ, Cain FC. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 1998;83:3930-5.